InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50
United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Rachna Khosla
13 Aug 2026
SVP, Business Development
Sold after exercise
1,252
$416.43
$521.36K
Nancy A. Grygiel
6 Aug 2026
SVP & CCO
Sold after exercise
1,000
$402.16
$402.16K
Nancy A. Grygiel
6 Aug 2026
SVP & CCO
Sold after exercise
1,970
$402.16
$792.26K
Derek Miller
6 Aug 2026
SVP, Human Resources
Sold after exercise
1,821
$402.54
$733.03K
Derek Miller
6 Aug 2026
SVP, Human Resources
Sold after exercise
2,069
$402.54
$832.86K
Esteban Santos
26 Feb 2026
EVP, Operations
Sold after exercise
24,291
$379.12
$9.21M
Esteban Santos
26 Feb 2026
EVP, Operations
Sold after exercise
30,501
$379.12
$11.56M
Nancy A. Grygiel
20 Nov 2025
SVP & CCO
Sold after exercise
1,639
$337.26
$552.77K
Nancy A. Grygiel
20 Nov 2025
SVP & CCO
Sold after exercise
1,500
$337.26
$505.89K
Derek Miller
19 Feb 2025
SVP, Human Resources
Sold after exercise
1,524
$293.74
$447.65K
David M Reese
19 Feb 2025
EVP & Chief Technology Officer
Sold after exercise
8,711
$293.22
$2.55M
Esteban Santos
19 Feb 2025
EVP, Operations
Sold after exercise
8,711
$292.84
$2.55M
Jonathan P Graham
7 Feb 2025
EVP & Gen. Counsel & Secy.
Sold after exercise
25,045
$293.12
$7.34M
Ronald D Sugar
12 May 2021
Director
Sold after exercise
1,000
$250.59
$250.59K
Nancy A. Grygiel
11 May 2021
SVP & CCO
Sold after exercise
2,500
$252.51
$631.27K
Ronald D Sugar
14 Apr 2021
Director
Sold after exercise
1,000
$249.98
$249.98K
Ronald D Sugar
10 Mar 2021
Director
Sold after exercise
1,000
$231.53
$231.53K
Ronald D Sugar
10 Feb 2021
Director
Sold after exercise
1,000
$238.40
$238.40K
Ronald D Sugar
13 Jan 2021
Director
Sold after exercise
1,000
$235.99
$235.99K
Ronald D Sugar
19 Aug 2020
Director
Sold after exercise
1,000
$241.02
$241.02K
Ronald D Sugar
22 Jul 2020
Director
Sold after exercise
1,000
$259.79
$259.79K
Ronald D Sugar
17 Jun 2020
Director
Sold after exercise
1,000
$228.54
$228.54K
Ronald D Sugar
20 May 2020
Director
Sold after exercise
1,000
$229.27
$229.27K
Ronald D Sugar
22 Apr 2020
Director
Sold after exercise
1,000
$233.35
$233.35K
Ronald D Sugar
6 Nov 2019
Director
Sold after exercise
2,000
$215.45
$430.90K
Ronald D Sugar
2 Oct 2019
Director
Sold after exercise
2,000
$193.58
$387.16K
Ronald D Sugar
4 Sep 2019
Director
Sold after exercise
2,000
$206.70
$413.40K
Cynthia M Patton
30 Aug 2019
SVP & CCO
Sold after exercise
4,802
$208.07
$999.14K
Cynthia M Patton
30 Aug 2019
SVP & CCO
Sold after exercise
2,875
$208.07
$598.19K
Cynthia M Patton
30 Aug 2019
SVP & CCO
Sold after exercise
5,749
$208.07
$1.20M
Ronald D Sugar
7 Aug 2019
Director
Sold after exercise
2,000
$183.04
$366.08K
Ronald D Sugar
3 Jul 2019
Director
Sold after exercise
2,000
$187.58
$375.16K
Ronald D Sugar
5 Jun 2019
Director
Sold after exercise
2,000
$175.68
$351.36K
Ronald D Sugar
1 May 2019
Director
Sold after exercise
2,000
$175.73
$351.46K
Ronald D Sugar
3 Apr 2019
Director
Sold after exercise
2,000
$193.18
$386.36K
Ronald D Sugar
6 Mar 2019
Director
Sold after exercise
2,000
$188.88
$377.76K
Ronald D Sugar
7 Feb 2019
Director
Sold after exercise
2,000
$190.00
$380.00K
Tyler Jacks
6 Dec 2018
Director
Sold after exercise
20,000
$195.41
$3.91M
Cynthia M Patton
29 Nov 2018
SVP & CCO
Sold after exercise
1,777
$202.88
$360.52K
Show all 96 transactions →

What was left out

Form 4 filings counted 780
Amendments (4/A) skipped 0
Filings about a different issuer 10
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 39
Sales at will 47
Transactions with no price 0
Shares from compensation/vesting 3,398,323
Sales filed before the plan box existed 31
History held since 4 Oct 2006